Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate

Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children/adolescents with ADHD: results of a 3-month non-interventional study

(2011) Christian Wolff et al.   CURRENT MEDICAL RESEARCH AND OPINION

A pharmacokinetic study of two modified-release methylphenidate formulations under different food conditions in healthy volunteers

(2011) F. Haessler et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Lack of bioequivalence between two methylphenidate extended modified release formulations in healthy volunteers

(2011) H. Schütz et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Academic, Behavioral, and Cognitive Effects of OROS® Methylphenidate on Older Children with Attention-Deficit/Hyperactivity Disorder

(2011) Sharon B. Wigal et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Pharmacokinetics and Therapeutic Effect of OROS® Methylphenidate Under Different Breakfast Conditions in Children with Attention-Deficit/Hyperactivity Disorder

(2011) Sharon B. Wigal et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Comparison of the Efficacy of Two Different Modified Release Methylphenidate Preparations for Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a Natural Setting: Comparison of the Efficacy of Medikinet® Retard and Concerta®—a Randomized, Controlled, Double-Blind Multicenter Clinical Crossover Trial

(2011) Manfred Döpfner et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

(2011)   PEDIATRICS

A Randomized, Single-Blind, Substitution Study of OROS Methylphenidate (Concerta) in ADHD Adults Receiving Immediate Release Methylphenidate

(2010) Thomas J. Spencer et al.   Journal of Attention Disorders

A Double-Blind, Randomized, Placebo/Active Controlled Crossover Evaluation of the Efficacy and Safety of Ritalin® LA in Children with Attention-Deficit/Hyperactivity Disorder in a Laboratory Classroom Setting

(2010) Eberhard Schulz et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants

(2009) Jan Buitelaar et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder

(2009) Lenard A. Adler et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Adverse Effects of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder

(2008) Johnny Graham et al.   CNS DRUGS

Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey

(2008) David Coghill et al.   Child and Adolescent Psychiatry and Mental Health